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Protein-protein interactions are often mediated by short
linear motifs (SLiMs) that are located in intrinsically dis-
ordered regions (IDRs) of proteins. Interactions medi-
ated by SLiMs are notoriously difficult to study, and
many functionally relevant interactions likely remain to
be uncovered. Recently, pull-downs with synthetic pep-
tides in combination with quantitative mass spectrometry
emerged as a powerful screening approach to study pro-
tein-protein interactions mediated by SLiMs. Specifically,
arrays of synthetic peptides immobilized on cellulose
membranes provide a scalable means to identify the in-
teraction partners of many peptides in parallel. In this
minireview we briefly highlight the relevance of SLiMs for
protein-protein interactions, outline existing screening
technologies, discuss unique advantages of peptide-
based interaction screens and provide practical sugges-
tions for setting up such peptide-based screens.
Most proteins interact with others to exert their biological
functions. Therefore, studying protein-protein interactions
(PPIs) provides mechanistic insights into the molecular pro-
cesses underlying health and disease. Traditionally, PPIs were
thought to be mediated by folded globular domains. Interac-
tions formed this way tend to be stable, often forming com-
plexes to fulfill tasks together as one molecular machinery.
However, cells also need to react to stimuli and adapt to their
environment in a flexible and versatile manner. To this end,
proteins pass on information in signaling cascades, interact
with each other for trafficking or are marked for degradation.
In all these cases proteins interact, but the system can only
function if these interactions are reversible and transient.
In the last decades it has become clear that also parts of
proteins that do not acquire a fixed three-dimensional struc-
ture can be involved in PPIs (1). In multicellular organisms,
around 40% of amino acid residues are in so-called intrinsi-
cally disordered regions (IDRs) (2). In recent years, the interest
in IDRs has been rising because they were found to play
critical roles in many biological processes. For example, IDRs
are particularly abundant in so-called hub proteins (i.e. pro-
teins with high connectivity in PPI networks), suggesting that
these regions are important mediators of PPIs (3). Indeed,
IDRs often harbor short linear motifs (SLiMs) - short regions of
typically less than ten amino acids that can mediate PPIs,
posttranslational modifications, or both (4, 5). The small infor-
mation content of SLiMs makes bioinformatic prediction
solely based on peptide sequences error-prone and care
must be taken while trying to establish new peptide-domain
connections (6). In addition, IDRs play a central role in liquid-
liquid phase separation—a process in which proteins come
together to form organelles without membrane confinement
(7, 8). The assembly of these organelles is driven by transient,
multivalent interactions (8, 9) and the liquid property is main-
tained through the constant formation and separation of these
interactions.
Studying PPIs that are mediated by IDRs is of paramount
importance for our understanding of cell biology. At the same
time, their reversible and transient nature makes it hard to
study such interactions experimentally (Fig. 1): Classical af-
finity purification mass spectrometry (AP-MS) is a very versa-
tile approach, especially when it is combined with quantifica-
tion (q-AP-MS) (10, 11). However, although AP-MS works very
well for stable interactions, it may fail to detect weak binding
mediated by SLiMs. Alternatively, proximity labeling ap-
proaches can reveal also weak interactions and thus be used
to map the proteomes of membraneless organelles (12, 13).
However, proximity labeling detects protein colocalization
and not necessarily PPIs. Also, any given protein contains
many potential SLiMs, and both AP-MS and proximity label-
ing do not provide sufficient information to assign an ob-
served interaction to a specific motif.
High throughput peptide-based interaction proteomics re-
cently emerged as a powerful technology to study PPIs me-
diated by IDRs. Here we review this methodology, discuss
practical implications involved in it and outline future perspec-
tives. To set the scene, we will begin with a brief overview of
existing methods to study peptide-mediated interactions.
Overview of Methods To Study Protein-Protein Interactions
Mediated by SLiMs—Despite the challenges outlined above,
IDRs have one inherent property that actually facilitates their
experimental analysis: They can exert their function independ-
ently of the context of the full-length protein. This means that
interactions mediated by SLiMs can be studied using short
peptides. This enables the design of screening methods to
systematically probe peptide-mediated interactions (Table I).
The methods to study peptide-mediated interactions can be
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broadly categorized into genetic and biochemical screens
(14).
Phage display, yeast two-hybrid (Y2H) and yeast surface
display are popular genetic screening methods to study pep-
tide-protein interactions. However, these methods suffer from
difficulties to identify interactions that rely on post-transla-
tional modifications (PTMs). This is an important limitation
because some PTMs are enriched in IDRs and often play an
important regulatory role (4, 15–17). Phage display libraries
covering all disordered regions of the human proteome have
been constructed (18). However, with few notable exceptions
(19), such libraries are typically screened against a rather
small set of preselected bait proteins. This is because of the
practical challenges associated with producing many individ-
ual bait proteins in parallel. Therefore, these approaches typ-
ically have a limited throughput (few protein baits against a
library of peptide preys).
Peptide-mediated interactions can also be studied bio-
chemically. A prerequisite for these assays was the develop-
ment of solid phase peptide synthesis, which enables the
chemical production of peptides with defined amino acid
sequences (30). Interaction assays with synthetic peptides
have the advantage that posttranslational modifications can
be directly incorporated into peptides during synthesis. Also,
instead of incorporating a defined amino acid at a given
position, it is possible to use a mix of different amino acids.
This yields a degenerate peptide library (that is, a peptide
mixture with random amino acids at specific positions). Al-
ready almost 30 years ago, the Lewis Cantley lab used such
a degenerate phosphopeptide library with an invariant phos-
photyrosine in the central position as prey in interaction
screens with immobilized Src Homology 2 (SH2) domains as
baits (31). Edman degradation of the bound peptides then
revealed the average amino acid composition at different
positions along the peptides and thus the “consensus”
binding motif recognized by the SH2 domain. This approach
is limited to the analysis of selected protein domains (one
bait against a library of peptide preys). The throughput on
the bait side can be increased by immobilizing the proteins/
domains on a protein microarray (24, 25). This however
reduces the throughput on the peptide side, because now
individual peptides (rather than a degenerate peptide li-
brary) must be tested. Protein microarrays are also quite
difficult to produce and limited to the detection of relatively
high affinity interactions.
Instead of immobilizing protein baits to pull-down peptides,
it is also possible to immobilize peptides as baits to pull down
interacting proteins. A key advantage of this set-up is that
peptides can be immobilized at high density. The resulting
high local peptide concentration allows enrichment of pro-
teins with low binding affinities. Another advantage is the
increased throughput: Multiple peptides with defined amino
acid composition can be synthesized in parallel via the so-
called SPOT synthesis (32). SPOT synthesis yields arrays of
thousands of different peptides immobilized on cellulose
membranes, even though quality control is more difficult in
this format (see below). Cellulose is an attractive support as it
is biocompatible, hydrophilic, inexpensive, environmentally
friendly, and stable under a wide range of reaction conditions
(33). Traditionally, peptide arrays on cellulose are probed with
a single prey protein that is subsequently detected by specific
antibodies or by fluorescent/radioactive labels on the prey
protein of interest (34). A common application for such pep-
tide arrays is to map the linear epitopes recognized by anti-
bodies (26) or to identify peptides that are recognized by
recombinantly expressed protein domains (35). This approach
is limited to a single prey protein that is studied at a time
(many peptide baits, single candidate prey).
The prey proteins interacting with immobilized peptides can
also be identified using mass spectrometry. In this case pep-
tides were usually coupled to beads. Importantly, because
peptide-protein interactions typically have low affinities, such
pull-down experiments require low stringency conditions,
which often results in many nonspecific binders. Therefore, it
is crucial to use quantitative mass spectrometry to assess
which interactions are truly specific. The general idea is to
perform parallel control pull-downs with suitable negative
controls (e.g. mutated or unmodified peptides). Quantitative
proteomics can then distinguish specific interaction partners
from unspecific background binders. This combination of
peptide pull-downs with quantitative proteomics was pio-
neered in 2004 by the Matthias Mann laboratory and has since
been successfully employed to study the impact of PTMs and
sequence motifs on peptide-protein interactions (36–39). In
these experiments, the number of preys is huge and corre-
FIG. 1. Studying protein-protein interactions experimentally.
Protein-protein interactions range from stable interactions involving
structured regions (left) to transient interactions involving intrinsically
disordered regions (right). Different experimental methods are more
suitable for specific types of interactions, also depending on binding
affinities.
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sponds to the complexity of protein lysate employed. In con-
trast, peptide baits are typically used in individual pull-down
experiments. This limits the number of peptide baits that can
be used in parallel (few peptide baits against a complex
proteome).
High Throughput Peptide-based Interaction Proteomics—
Recently, the advantageous parts of both above-mentioned
peptide pull-down approaches have been combined (Fig. 2):
Instead of probing a peptide array with a single prey protein,
peptide arrays were probed with whole cell lysates and inter-
acting proteins were identified using quantitative mass spec-
trometry (28, 29, 40). In all three cases, 14–18 mer peptides
were synthesized on cellulose membranes via the SPOT tech-
nology that were then incubated with cell extracts to identify
binding partners via mass spectrometry. This set-up, coined
“Protein Interaction Screen on Peptide Matrix” (PRISMA) by
Dittmar and co-workers, has the advantage that it enables
interaction screens with high-throughput for both baits and
preys (many peptide baits against a complex proteome as
prey).
The three above-mentioned publications employed the
overall concept to address biological questions from different
angles. Okada et al. incorporated photoactivatable amino ac-
ids into their peptides and used photocrosslinking to cova-
lently trap interacting proteins (40). Although this enabled high
stringency washing conditions, the list of identified proteins
still contained numerous unspecific contaminants. The two
other studies therefore employed quantification to distinguish
specific from nonspecific binders. Dittmar and co-workers
used a sliding window approach (overlapping “tiled” peptides)
to map binding partners along the sequence of C/EBPbeta
(28). They also assessed the impact of PTMs because SPOT
synthesis permits inclusion of phosphorylation, methylation
(mono, di, tri), citrullination, acetylation, crotonylation, sumoy-
lation and many more. In our own work, we used PRISMA to
study how disease-causing mutations in disordered regions
of proteins lead to changes in protein-protein interactions
(29). Here, we combined label-free quantification (41) and
stable isotope labeling by amino acids in cell culture (SILAC)
(42) to determine specific interaction partners and the impact
of the mutation on the interaction, respectively.
Practical Considerations—Several practical points should
be considered when designing a PRISMA screen. First, an
overall experimental design and a strategy for data analysis
and quantification are needed: Because the proteins identified
in peptide pull-down experiments will be dominated by non-
specific interactors, it is critical to design a sound quantifica-
tion strategy to single out specific interactors. Quantification
methods such as label-free quantification, SILAC and chem-
ical labeling are all possible options (43). Which of these
methods is best suited for a given PRISMA screen depends
on the aims of this screen. Key questions in this context are:
FIG. 2. Peptide-based interaction
proteomics. Interaction partners of short
disordered peptide regions can be deter-
mined using peptide-pulldowns from a
complex protein mixture. To this end,
peptides are synthesized on a cellulose
membrane, which allows for either N- or
C-terminal coupling, analyses of mutated
sequences or insertion of various post-
translational modifications. After incuba-
tion of the membrane with a protein
extract, interacting proteins can be
identified via mass spectrometry.
Quantification can then reveal which in-
teractions are specific for a given pep-
tide sequence or modification.
TABLE I
Overview of screening methods to study peptide-protein interactions
Peptide library size Domains/Proteins Source
Proteomic peptide-phage display (ProP-PD) 10,000–1,000,000 10 (18, 20)
Y2H 100,000,000 50 (21, 22)
Yeast surface display 100,000,000 5 (14, 23)
Protein microarray 100 200 (24, 25)
Peptide array (classical) 1,000;  1,000,000 (high-density array) 10 (26, 27)
Peptide array ( mass spec) 1,000 Whole proteome (28, 29)
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To which control(s) will any given peptide pull-down be com-
pared? Which statistical strategy will be used to identify spe-
cific binding? How many replicates are needed? Which pos-
itive and negative controls should be included in the screen?
The second question is how the cellulose arrays will be ob-
tained. Although SPOT synthesis can be performed manually
(44), it is more convenient to use a dedicated machine like the
MultiPep synthesizer (Intavis AG, Köln, Germany) for this pur-
pose (34). Alternatively, custom peptide arrays can be directly
ordered from companies such as JPT Peptide Technologies
(Berlin, Germany). Those peptide spots have a diameter of
2–3 mm and a typical yield between 5–10 nmol (8–17 g for
an average 15-mer peptide). This high local concentration facil-
itates identification of low affinity interactions.
Third, irrespective of how the SPOT synthesis is carried out,
several points should be considered when designing peptide
sequences. Fmoc based solid phase peptide synthesis pro-
ceeds from the C terminus toward the N terminus, i.e. in the
opposite direction of biological peptide synthesis (45). Stand-
ard SPOT synthesis therefore results in peptides that are
immobilized via their C terminus and a free N terminus. It is
usually beneficial to synthesize the peptides with an acety-
lated N terminus, because this (i) eliminates the positive
charge and thus better reflects the situation within a protein
sequence in which the N terminus participates in an amide
bond and (ii) makes the peptide more stable (46). Because
peptides immobilized via their C termini are not suitable to
screen for interaction partners of free C termini, methods to
invert the peptide on the membrane have also been devel-
oped (47). It is also important to keep in mind that the yield of
individual coupling steps is not 100%. Therefore, the yield of
correctly synthesized full-length peptides decreases with in-
creasing peptide length, which is why peptides should not be
longer than about 15 amino acids. Fortunately, this is in good
agreement with the fact that SLiMs are typically less than 10
amino acids in length (4, 5). Also, specific combinations of
amino acids are notoriously difficult to synthesize (48, 49). The
failure to incorporate an amino acid in one coupling cycle
leads to a peptide with a deletion at this position. Such
deletions can be prevented by incorporating a capping step,
which blocks defective peptide chains in subsequent synthe-
sis cycles (50). Although this results in truncated peptides, it
should reduce the risk of false positive identifications arising
from peptides with erroneous sequences.
The amino acid composition of the peptides is another
important factor. If the peptide contains cysteines, the forma-
tion of disulfide bonds between the peptide and a protein
might lead to false-positive results. In these cases, adding a
reducing agent during the incubation step should be consid-
ered, which however must be compatible with the chemistry
used for peptide immobilization. Also, although peptides are
typically not eluted from the cellulose and therefore not iden-
tified in the mass spectrometer, sequences which contain a
cleavage site for the used protease (e.g. R/K for trypsin) will
also be digested and hence become an abundant peptide
species in the mass spec measurement. To avoid misidenti-
fications, they should therefore be included in the protein
sequence database against which mass spectra are later
searched.
For the actual pull-down experiment, it is advantageous to
use a cell extract that contains the putative interaction part-
ners. For example, for interactions in the neuronal context it
makes sense to use extract from neuronal cell lines (29), and
for interaction partners of nuclear proteins nuclear extracts
are a good choice (28). Whatever extract is used, it should be
rather concentrated (5 mg protein/ml) to increase the sensi-
tivity of the screen (28, 29). Approximately 10 ml of lysate are
needed to cover an array with 200 spots (30 cm2, peptide
grid: 0.37 cm 0.37 cm, JPT). It is generally recommended to
perform the pull-downs at 4 °C and to use protease inhibitors.
However, the final washing buffer should not contain protease
inhibitors to ensure efficient subsequent digestion. After the
pulldown washing, the cellulose membranes can be air dried
and stored. For sample preparation individual spots need to
be excised from the cellulose membrane and transferred into
individual wells of a 96-well plate. We found that a mouse ear
puncher is a helpful tool for this step and that dry membranes
are easier to handle than wet ones. Because of electrostatic
effects, the excised spots tend to be repelled from the wells of
96-well plates, hence it has proven useful to already fill the
wells with the digestion buffer. Reduction, alkylation, and
digestion can then all be performed in 96-well format.
A key factor for the mass spectrometric measurements is
the length of the chromatographic gradient and thus the total
measurement time needed for the screen. In our experience,
the complexity of individual pull-down samples is rather low (a
few hundred proteins), which permits relatively short analysis
times on the mass spectrometer. The length of the gradient
should be adapted to the required depth of proteomic cover-
age, for example based on the positive control samples.
For the interpretation of results, it is important to keep in
mind that PRISMA is an in vitro screening method: The com-
bination of cell lysates with the bait might bring together
interaction partners that never meet under physiological con-
ditions and thus lead to false positive identifications. Hence,
before any biological conclusion can be drawn from the data,
specific follow-up experiments under more physiological con-
ditions are required for validation.
Conclusions and Outlook—As outlined above, PRISMA
screening is a powerful technology to study PPIs that are
mediated by short linear motifs (SLiMs) in disordered protein
regions (IDRs). This will help characterize new SLiM-domain
interaction pairs, by providing valuable insight on sequence
recognition specificity. Getting better insight into the rules that
guide these transient interactions might help us answer dif-
ferent questions in molecular/cellular biology, as for example
how protein-protein interaction leads to formation of conden-
sates via liquid-liquid phase separation (8) or provide hints on
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the functions of newly emerging miniproteins (51). Some de-
tected peptides might also activate or inhibit the activity of
their interaction partner and hence serve diagnostic or thera-
peutic purposes.
The PRISMA methodology is scalable and can already
produce data for dozens of peptides per day. In the future,
further automation of sample preparation, faster mass spec-
trometers and HPLC systems like the Evosep system (52)
will enable analysis of over 100 samples per day. Combina-
tion with multiplexing via TMTpro (53) enables quantification
and combined measurement of up to 16 samples, which
effectively leads to about 1600 analyses per day. For exam-
ple, using 16plex TMTpro would allow for alanine scanning
of a 15 amino acid long peptide in every position and
comparing it to the interactome of the wild type peptide in a
single run. We thus predict that peptide-based interaction
proteomics will continue to provide us with invaluable in-
sights in the exciting realm of disordered regions, short
linear motifs, and their function.
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